These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 14262229)
1. THREE EVALUATIONS OF A MONOAMINE OXIDASE INHIBITOR AND PHENOTHIAZINE COMBINATION (A METHODOLOGICAL AND CLINICAL STUDY). WINKELMANN W Dis Nerv Syst; 1965 Mar; 26():160-4. PubMed ID: 14262229 [No Abstract] [Full Text] [Related]
2. [SUCCINET REFLECTIONS ON THE CLINICAL USE OF ANTIDEPRESSIVE AGENTS]. BOBON J; GOFFIOUL F; COLLARD J; BREULET M Encephale; 1964; 53():479-84. PubMed ID: 14222722 [No Abstract] [Full Text] [Related]
3. Tranylcypromine and trifluoperazine in the management of the menopausal syndrome. MAZZA PA Dis Nerv Syst; 1962 Apr; 23():224-5. PubMed ID: 14471846 [No Abstract] [Full Text] [Related]
4. [STUDIES ABOUT A NEW DRUG ASSOCIATION]. OBARRIO JM; FERRERO RG; FABREGAS G Sem Med; 1963 Jul; 123():71-3. PubMed ID: 14091087 [No Abstract] [Full Text] [Related]
5. A COMPARISON OF TRANYLCYPROMINE ALONE WITH TRANYLCYPROMINE PLUS TRIFLUOPERAZINE IN THE TREATMENT OF CHRONIC OUTPATIENTS: A DOUBLE-BLIND CONTROLLED STUDY. MENA A; HEISTAD G; SCHIELE BC; JANECEK J J Neuropsychiatr; 1964 Dec; 5():542-50. PubMed ID: 14246556 [No Abstract] [Full Text] [Related]
6. [BIOLOGICAL AND PHARMACOLOGICAL ACTIVITY OF MONOAMINE OXIDASE INHIBITORS: THE ASSOCIATION OF TRANYLCYPROMINE AND TRIFLUOPERAZINE IN THE THERAPY OF DEPRESSIVE SYNDROMES]. GRATTAROLA FR; ROSSO G; ROVERA GG Clin Ter; 1963 Sep; 26():406-30. PubMed ID: 14091908 [No Abstract] [Full Text] [Related]
7. COMPARISONS OF DIAZEPAM, CHLORPROMAZINE AND TRIFLUOPERAZINE IN A DOUBLE-BLIND CLINICAL INVESTIGATION. SMITH ME; CHASSAN JB J Neuropsychiatr; 1964 Dec; 5():593-600. PubMed ID: 14246561 [No Abstract] [Full Text] [Related]
10. [Monoamine oxidase inhibitors in the treatment of obsessive disorders. Two case reports and review of the literature]. Erfurth A; Schmauss M Nervenarzt; 1993 Jan; 64(1):70-2. PubMed ID: 8437650 [TBL] [Abstract][Full Text] [Related]
11. Indications for the use of tranylcypromine and trifluoperazine (Parstelin). Lyons HA; Degerli M Scott Med J; 1978 Oct; 23(4):307-9. PubMed ID: 725583 [TBL] [Abstract][Full Text] [Related]
12. [A NEW ANXIOLYTIC USEFUL IN GENERAL MEDICINE: RO 5-2807, A NEW DERIVATIVE OF BENZODIAZEPINE]. NAVARRANNE P; FRITZ A; MARION J; TAFANI A Therapie; 1964; 19():1365-73. PubMed ID: 14227796 [No Abstract] [Full Text] [Related]
16. PRR STUDY NO. 3. (A METHOD FOR CONTROLLING THE ADMINISTRATION OF TRANYLCYPROMINE). MELDMAN MJ Dis Nerv Syst; 1964 Aug; 25():496-501. PubMed ID: 14199199 [No Abstract] [Full Text] [Related]
17. A CONTROLLED TRIAL WITH 'VALIUM' IN OBSESSIVE COMPULSIVE STATE. VENKOBARAO A J Indian Med Assoc; 1964 Jun; 42():564-7. PubMed ID: 14169176 [No Abstract] [Full Text] [Related]
18. A FIVE-YEAR FOLLOW-UP OF 100 NEUROTIC OUT-PATIENTS. GIEL R; KNOX RS; CARSTAIRS GM Br Med J; 1964 Jul; 2(5402):160-3. PubMed ID: 14150889 [No Abstract] [Full Text] [Related]
19. SUPPRESSION OF ANXIETY WITH OXAZEPAM IN A PRIVATE PSYCHIATRIC PRACTICE. KRAKOWSKI AJ Psychosomatics; 1965; 6():26-31. PubMed ID: 14263746 [No Abstract] [Full Text] [Related]
20. THE FEAR OF FLYING SYNDROME: A RE-APPRAISAL. SOURS JE; EHRLICH RE; PHILLIPS PB Aerosp Med; 1964 Feb; 35():156-66. PubMed ID: 14121992 [No Abstract] [Full Text] [Related] [Next] [New Search]